EE03492B1 - Mitte-autoinaktiveeruvad ekspressiooni suunavad retroviiruslikud vektorid - Google Patents

Mitte-autoinaktiveeruvad ekspressiooni suunavad retroviiruslikud vektorid

Info

Publication number
EE03492B1
EE03492B1 EE9700040A EE9700040A EE03492B1 EE 03492 B1 EE03492 B1 EE 03492B1 EE 9700040 A EE9700040 A EE 9700040A EE 9700040 A EE9700040 A EE 9700040A EE 03492 B1 EE03492 B1 EE 03492B1
Authority
EE
Estonia
Prior art keywords
region
auto
retroviral vectors
direct expression
inactivating retroviral
Prior art date
Application number
EE9700040A
Other languages
English (en)
Other versions
EE9700040A (et
Inventor
Henry G�nzburg Walter
Michael Saller Robert
Original Assignee
GSF-Forschungszentrum f�r Umwelt und Gesundheit GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GSF-Forschungszentrum f�r Umwelt und Gesundheit GmbH filed Critical GSF-Forschungszentrum f�r Umwelt und Gesundheit GmbH
Publication of EE9700040A publication Critical patent/EE9700040A/et
Publication of EE03492B1 publication Critical patent/EE03492B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Ceramic Products (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Traffic Control Systems (AREA)
  • Navigation (AREA)
  • Road Signs Or Road Markings (AREA)
  • Molds, Cores, And Manufacturing Methods Thereof (AREA)
  • Electrotherapy Devices (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
EE9700040A 1994-09-02 1995-09-01 Mitte-autoinaktiveeruvad ekspressiooni suunavad retroviiruslikud vektorid EE03492B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK101794 1994-09-02
PCT/EP1995/003445 WO1996007748A1 (en) 1994-09-02 1995-09-01 Non self-inactivating, expression targeted retroviral vectors

Publications (2)

Publication Number Publication Date
EE9700040A EE9700040A (et) 1997-08-15
EE03492B1 true EE03492B1 (et) 2001-08-15

Family

ID=8100062

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700040A EE03492B1 (et) 1994-09-02 1995-09-01 Mitte-autoinaktiveeruvad ekspressiooni suunavad retroviiruslikud vektorid

Country Status (21)

Country Link
US (1) US7531353B1 (et)
EP (1) EP0779929B1 (et)
JP (1) JP4037446B2 (et)
CN (1) CN1117156C (et)
AT (1) ATE200517T1 (et)
AU (1) AU688590B2 (et)
BR (1) BR9508664A (et)
CA (1) CA2198210C (et)
DE (1) DE69520681T2 (et)
DK (1) DK0779929T5 (et)
EE (1) EE03492B1 (et)
ES (1) ES2156945T3 (et)
FI (1) FI970892A (et)
HK (1) HK1001527A1 (et)
HU (1) HU221607B (et)
MX (1) MX9701544A (et)
NO (1) NO317731B1 (et)
NZ (1) NZ292897A (et)
PL (1) PL184375B1 (et)
RU (1) RU2199585C2 (et)
WO (1) WO1996007748A1 (et)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2199585C2 (ru) 1994-09-02 2003-02-27 ГСФ-Форшунгсцентрум фюр Умвельт унд Гезундхайт ГмбХ Ретровирусная векторная конструкция, подвергающаяся промоторной конверсии, способ введения гомологичных или гетерологичных нуклеотидных последовательностей в человеческие или животные клетки in vitro и/или in vivo, рекомбинантная ретровирусная частица, фармацевтическая композиция для генной терапии
PT817858E (pt) 1995-03-09 2003-09-30 Gsf Forschungszentrum Umwelt U Preparacoes fotoprotectoras que compreendem derivados de triazina
DK0835137T3 (da) 1995-06-27 2006-03-06 Bavarian Nordic As Indkapslede celler, som danner viruspartikler
US7074398B1 (en) 1995-10-13 2006-07-11 Gsf-Forschungszentrum Fuer Umwelt Und Gesundheit Gmbh Retroviral vectors carrying senescent cell derived inhibitors 1 (SDI-1)or antisense SDI-1 nucleotide sequences
AU7291696A (en) * 1995-10-13 1997-04-30 Bavarian Nordic Research Institute A/S Retroviral vectors carrying senescent cell derived inhibitors 1 (sdi-1) or antisense sdi-1 nucleotide sequences
PL188323B1 (pl) 1996-03-27 2005-01-31 Bavarian Nordic As Kapsuła zawierająca komórki i jej zastosowanie oraz kompozycja i środek farmaceutyczny
US6540995B1 (en) 1996-03-27 2003-04-01 Bavarian Nordic Research Institute Gmbh Encapsulated cells producing cytochrome P450
EP0961830A1 (en) * 1997-01-29 1999-12-08 Neurosearch A/S EXPRESSION VECTORS AND METHODS FOR $i(IN VIVO) EXPRESSION OF THERAPEUTIC POLYPEPTIDES
DK1895010T3 (da) * 1997-12-22 2011-11-21 Oxford Biomedica Ltd Vektorer baseret på virus for infektiøs hesteanæmi (eiav)
ATE278029T1 (de) 1998-01-06 2004-10-15 Inst Virologie Teilrechtsfaehi Rekonstituierender retroviraler vektor (recon vektor) für gezielte genexpression
FR2778670B1 (fr) * 1998-05-18 2002-12-13 Rhone Poulenc Rorer Sa Methodes et compositions pour la production de particules virales
DE19910650A1 (de) * 1999-03-10 2000-09-21 Gsf Forschungszentrum Umwelt Auf HERV-LTR-Sequenzen basierende retrovirale Expressionsvektoren
CA2371946A1 (en) * 1999-04-29 2000-11-09 Aarhus University Expression of heterologous genes from an ires translational cassette in retroviral vectors
WO2002064805A2 (en) * 2001-02-09 2002-08-22 Institut für Virologie Teilrechtsfähiges Institut an der Veterinärmedizinischen Universität Wien Replication competent non-mammalian retroviral vectors
DE102009021592A1 (de) * 2009-05-15 2010-11-18 Medizinische Hochschule Hannover ASLV-Vektorsystem

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989011539A1 (en) 1988-05-17 1989-11-30 Sloan-Kettering Institute For Cancer Research Retroviral vector
GB8919607D0 (en) * 1989-08-30 1989-10-11 Wellcome Found Novel entities for cancer therapy
WO1994029437A1 (en) * 1993-06-07 1994-12-22 University Of Medicine & Dentistry Of New Jersey Highly-efficient, self-inactivating, recombination-free, u3-free retroviral vectors
RU2199585C2 (ru) 1994-09-02 2003-02-27 ГСФ-Форшунгсцентрум фюр Умвельт унд Гезундхайт ГмбХ Ретровирусная векторная конструкция, подвергающаяся промоторной конверсии, способ введения гомологичных или гетерологичных нуклеотидных последовательностей в человеческие или животные клетки in vitro и/или in vivo, рекомбинантная ретровирусная частица, фармацевтическая композиция для генной терапии
PT817858E (pt) * 1995-03-09 2003-09-30 Gsf Forschungszentrum Umwelt U Preparacoes fotoprotectoras que compreendem derivados de triazina
AU5104096A (en) * 1995-03-09 1996-10-02 Bavarian Nordic Research Institute A/S Novel recombinant dna vectors for gene therapy
US6117681A (en) * 1995-03-29 2000-09-12 Bavarian Nordic Research Inst. A/S Pseudotyped retroviral particles
GB9510272D0 (en) 1995-05-22 1995-07-19 Isis Innovation Retroviral vectors
US7074398B1 (en) * 1995-10-13 2006-07-11 Gsf-Forschungszentrum Fuer Umwelt Und Gesundheit Gmbh Retroviral vectors carrying senescent cell derived inhibitors 1 (SDI-1)or antisense SDI-1 nucleotide sequences

Also Published As

Publication number Publication date
CN1117156C (zh) 2003-08-06
AU688590B2 (en) 1998-03-12
BR9508664A (pt) 1998-01-06
AU3520195A (en) 1996-03-27
RU2199585C2 (ru) 2003-02-27
HU221607B (hu) 2002-11-28
NZ292897A (en) 1998-08-26
PL184375B1 (pl) 2002-10-31
DK0779929T3 (da) 2001-05-07
NO317731B1 (no) 2004-12-13
JP4037446B2 (ja) 2008-01-23
NO970902L (no) 1997-04-24
EE9700040A (et) 1997-08-15
WO1996007748A1 (en) 1996-03-14
FI970892A0 (fi) 1997-02-28
CN1159210A (zh) 1997-09-10
DE69520681D1 (de) 2001-05-17
ES2156945T3 (es) 2001-08-01
ATE200517T1 (de) 2001-04-15
MX9701544A (es) 1998-03-31
PL319033A1 (en) 1997-07-21
JPH10507628A (ja) 1998-07-28
DE69520681T2 (de) 2001-11-29
EP0779929B1 (en) 2001-04-11
FI970892A (fi) 1997-02-28
HUT76974A (hu) 1998-01-28
NO970902D0 (no) 1997-02-27
CA2198210A1 (en) 1996-03-14
US7531353B1 (en) 2009-05-12
CA2198210C (en) 2006-07-11
HK1001527A1 (en) 1998-06-26
EP0779929A1 (en) 1997-06-25
DK0779929T5 (da) 2001-08-13

Similar Documents

Publication Publication Date Title
EE03492B1 (et) Mitte-autoinaktiveeruvad ekspressiooni suunavad retroviiruslikud vektorid
WO1998039463A3 (en) Lentivirus based vector and vector system
DE69429631T2 (de) Conotoxinpeptide
DE69615682D1 (de) N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1-h-benzo[b][1,5]-diazepin-3-yl)-acetamide
NO953462D0 (no) Heterosykliske forbindelser og deres fremstilling og anvendelse
DE69233785D1 (de) diert
EE9900581A (et) LAG-3 pleissimisteisendid
ES2193241T3 (es) Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas.
DE59509910D1 (de) Verfahren zur Herstellung von Alkylhydrogenchlorsilanen
CA2267945A1 (en) Anticonvulsant derivatives useful in treating neuropathic pain
DE59109072D1 (de) Klonierung der N-Methylhydantoinase
ES2194102T3 (es) Nuevas n-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas.
DE69321235T2 (de) Promoter vom k. lactis pyruvat-decarboxylase gen und anwendung davon
ID20153A (id) Proses polimerisasi etilena dengan adanya suatu katalis kromium oksida
ATE89005T1 (de) Rekombinantes vektorsystem fuer metalloproteinase- inhibitorsequenz und dessen verwendung und herstellung nach dem rekombinant-dns-verfahren.
MX9605731A (es) Preparacion de un catalizador de hidratacion con empleo de m(or)mxn.
ZA845842B (en) 5-substituted(1,2,4,)triazolo(1,5-c)pyrimidin-2-amines
UA20042A (uk) Біс-n,n-диметил-n-(2-гідрокси-3-бутоксипропіл) аміhо-ізо-фталімід як латеhтhий каталізатор отвердіhhя епоксидhих композицій
UA20041A (uk) Біс-n,n-диметил-n-(2-гідрокси-3-бутоксипропіл) аміhоадипоілімід як латеhтhий каталізатор отвердіhhя епоксидhих композицій
DE69418050D1 (de) Antivirale analoge von difluorostaton
DE59109126D1 (de) N-Carbamoylsarcosin-Amidohydrolase, kloniert
MX9707249A (es) Catalizador y proceso para la hidrogenacion de olefinas o polimeros.
DE69729098D1 (de) Fluorierung von ketoamiden

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20110901